NCT04681001View on ClinicalTrials.gov

Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care Workers

NACompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

December 20, 2020

Primary Completion Date

August 20, 2021

Study Completion Date

August 30, 2021

Conditions
Respiratory Viral InfectionCommon ColdSevere Acute Respiratory Syndrome (SARS) PneumoniaCOVID-19Corona Virus Disease
Interventions
DEVICE

nasal spray

application of nasal spray into nostrils and mouth

Trial Locations (2)

1100

Gesundheitsverbund, Klinik Favoriten, Vienna

1210

Gesundheitsverbund Klinik Floridsdorf, Vienna

Sponsors
All Listed Sponsors
lead

Marinomed Biotech AG

INDUSTRY

NCT04681001 - Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care Workers | Biotech Hunter | Biotech Hunter